| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8519165 | Contemporary Clinical Trials Communications | 2018 | 6 Pages |
Abstract
Whilst avoiding lengthy and complex PICF documents may assist with initial trial engagement, it needs to be supplemented with other strategies to support ongoing trial interest to randomisation and beyond. Participants refused trial participation throughout the screening phase indicating that the PICF was only one factor among several affecting an individual's decision to participate in this clinical trial.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Fleur O'Hare, Simone Spark, Zachary Flanagan, Stephane Heritier, Andrea Curtis, Sophia Zoungas, the STAREE Investigator Group the STAREE Investigator Group,